National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
THEOPHYLLINE EXTENDED-RELEASE TA
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00182-1400-89 | 0LXM4 | A | 5 | 2 | 4 | ZZ | ||
| THEO-DUR | 1F095 | A | 5 | 1 | 4 | KX | ||
| NDC00258-3581-01 | 6X308 | A | 5 | 1 | 4 | ZZ | ||
| NDC61570-0019-01 | 09GL2 | A | 5 | 1 | 4 | ZZ | ||
| NDC00904-1612-61 | 0SYT3 | A | 5 | 2 | 4 | ZZ | ||
| NDC00677-0817-01 | 59225 | A | 5 | 2 | 4 | ZZ | ||
| NDC00603-5946-21 | 0ET99 | A | 5 | 1 | 4 | ZZ | ||
| NDC00369-0803-81 | 24214 | H | 5 | 9 | 9 | 54 | ||
| NDC00456-4330-01 | 65050 | A | 5 | 2 | 4 | ZZ | ||
| THEO-DUR | 24214 | H | 5 | 9 | 9 | 54 | ||
| NDC50111-0459-01 | 3PYX2 | A | 5 | 2 | 4 | ZZ | ||
| NDC00085-0584-81 | 1F095 | A | 3 | 2 | 4 | KX |
CAGE Information
| Code | Company |
|---|---|
| 09GL2 | MONARCH PHARMACEUTICALS INC |
| 0LXM4 | IVAX |
| 1F095 | SCHERING-PLOUGH CORPORATION |
| 6X308 | INWOOD LABORATORIES INC |
| 0SYT3 | MAJOR PHARMACEUTICALS INC |
| 59225 | BAXTER HEALTHCARE CORP BAXTER AIRLIF |
| 0ET99 | GENERICS BIDCO I LLC DBA QUALITEST P |
| 24214 | KEY PHARMACEUTICALS INC |
| 65050 | FOREST PHARMACEUTICALS INC SUB OF FO |
| 3PYX2 | PLIVA INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| SUWT | UNIT OF ISSUE WEIGHT | 0.264 POUNDS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| THPE | THERAPEUTIC EQUIVALENT | THEO-DUR BY KEY PHARM |
| EXME | EXTERIOR CONTAINER CUBIC MEASURE | 3.00 CUBIC FEET |
| CBBL | FEATURES PROVIDED | UNIT DOSE |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| SUCB | UNIT OF ISSUE CUBE | 0.0208 CUBIC FEET |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG |
| EXQT | EXTERIOR CONTAINER QUANTITY | 144 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| ECWT | EXTERIOR CONTAINER WEIGHT | 38.00 POUNDS |